Home / Generics

Generics

News

IDT Australia gets FDA nod for 23 generics posted 17/04/2015

IDT Australia announced on 13 April 2015 that the US Food and Drug Administration (FDA) had accepted the transfer of ownershi...

Shire grabs Par’s attention with patent lawsuit posted 04/04/2015

Shire has served its rival Par Pharmaceutical (Par) with a patent infringement lawsuit in New Jersey Federal Court over Par's...

Actavis loses Atelvia patents posted 27/03/2015

Teva Pharmaceutical Industries (Teva) has won a legal battle against Actavis after a federal judge invalidated two patents pr...

Ranbaxy fails to reverse FDA decision over Valcyte and Nexium posted 20/03/2015

Indian generics company Ranbaxy has yet again failed in its bid to become the first company in the US to sell generic version...

Drug companies seek to block generic version of ulcerative colitis therapy posted 17/03/2015

The patent holder and manufacturer of Uceris (budesonide), a treatment for ulcerative colitis, have sued generics company Act...

 

Research

Safety and cost considerations of generic and originator gabapentin posted 17/04/2015

The launch of generic garbapentin prompted researchers from the Chulalongkorn University and the King Chulalongkorn Memorial...

Brazilian patients positive about generics posted 17/04/2015

A study looking at patients perceptions on generics in Brazil concludes that, although Brazilian patients have a positive att...

Effectiveness of generic and originator gabapentin in lower back pain posted 17/04/2015

Researchers from the Chulalongkorn University and the King Chulalongkorn Memorial Hospital in Bangkok, Thailand, carried out...

Comparison of generic and originator gabapentin posted 17/04/2015

The cost of treatment for patients with neuropathic lower back pain is higher than those with non-neuropathic lower back pain...

Generics utilization policies necessary to sustain Medicaid posted 10/04/2015

A review of the history and expansion of generics utilization policies and their critical role in the US Medicaid system in a...

 

General

France outlines plans to promote generics posted 10/04/2015

The French are in general mistrusting of generics with many choosing to stay with brand-name drugs. However, in 2012, in orde...

Dr Reddy’s US drug pricing comes under scrutiny posted 03/04/2015

Dr Reddy’s Laboratories, the India-based generics drugmaker, has been asked to share drug-pricing information with the attorn...

Health Canada clamps down on GMP compliance posted 20/03/2015

Canada’s federal health department Health Canada has written to its licensed drug and active pharmaceutical ingredients (API)...

FDA cash to develop hard-to-copy generics posted 20/03/2015

The US Food and Drug Administration (FDA) is offering US$850,000 to research teams working on generics development. Funds wil...

Pfizer warns UK doctors not to prescribe generic Lyrica for pain posted 20/03/2015

Pharma giant Pfizer is fighting hard to protect one of its brand-name products, this time its epilepsy treatment Lyrica (preg...

Generics News Research General

more

Biosimilars News Research General

more